Clinical Efficacy of Bevacizumab in the Treatment of Platinum Resistant Recurrent Advanced Ovarian Cancer

Clinical Efficacy of Bevacizumab in the Treatment of Platinum Resistant Recurrent Advanced Ovarian Cancer

ZHAN Yan

PDF(1051 KB)

PDF(1051 KB)

Chinese And Foreign Medical Research ›› 2025, Vol. 23 ›› Issue (9) : 23-26. DOI: 10.14033/j.cnki.cfmr.2025.09.007

Article

Clinical Efficacy of Bevacizumab in the Treatment of Platinum Resistant Recurrent Advanced Ovarian Cancer

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 23(9): 23-26 https://doi.org/10.14033/j.cnki.cfmr.2025.09.007

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1051 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉